Stay updated on BGB324 with Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the BGB324 with Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the BGB324 with Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    - Removed MedlinePlus Genetics topic on Melanoma. - Overall content scope related to genetics topics has been decreased (no compensating additions).
    Difference
    0.2%
    Check dated 2025-10-13T03:18:43.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Major update: new operating-status notice and version upgrade to v3.2.0; removal of the old v3.1.0 tag.
    Difference
    3%
    Check dated 2025-10-05T22:47:23.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Updated the page revision from v3.0.2 to v3.1.0, indicating a new software release or document update. No other substantive content changes are indicated.
    Difference
    0.1%
    Check dated 2025-09-28T19:29:14.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2. The 'Back to Top' link was removed.
    Difference
    0.2%
    Check dated 2025-09-14T07:52:11.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1.
    Difference
    0.2%
    Check dated 2025-09-07T02:11:31.000Z thumbnail image
  7. Check
    49 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location, as well as the introduction of new medical terms related to skin and connective tissue diseases and specific drugs like pembrolizumab. Notably, several previous terms and resources have been removed, indicating a shift in focus or content strategy.
    Difference
    2%
    Check dated 2025-08-31T00:42:46.000Z thumbnail image

Stay in the know with updates to BGB324 with Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the BGB324 with Pembrolizumab in Melanoma Clinical Trial page.